These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11121077)

  • 1. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation.
    Dostmann WR; Taylor MS; Nickl CK; Brayden JE; Frank R; Tegge WJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14772-7. PubMed ID: 11121077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase Ialpha.
    Dostmann WR; Tegge W; Frank R; Nickl CK; Taylor MS; Brayden JE
    Pharmacol Ther; 2002; 93(2-3):203-15. PubMed ID: 12191612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
    Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
    Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper.
    Dostmann WR; Nickl C; Thiel S; Tsigelny I; Frank R; Tegge WJ
    Pharmacol Ther; 1999; 82(2-3):373-87. PubMed ID: 10454213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture conditions influence uptake and intracellular localization of the membrane permeable cGMP-dependent protein kinase inhibitor DT-2.
    Foley KF; De Frutos S; Laskovski KE; Tegge W; Dostmann WR
    Front Biosci; 2005 May; 10():1302-12. PubMed ID: 15769626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha.
    Nickl CK; Raidas SK; Zhao H; Sausbier M; Ruth P; Tegge W; Brayden JE; Dostmann WR
    Biochim Biophys Acta; 2010 Mar; 1804(3):524-32. PubMed ID: 20018259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and systemic hypertension by selective cGMP-dependent protein kinase I inhibition using novel cell-penetrating peptide delivered in vivo.
    Poh KK; Lu P; Qin G; Silver M; Losordo DW; Mendelsohn ME; Zhu Y
    Int J Cardiol; 2013 Sep; 167(5):2114-9. PubMed ID: 22748498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of cGMP-dependent protein kinase-specific inhibitors probed by photoaffinity cross-linking mass spectrometry.
    Pinkse MWH; Rijkers DTS; Dostmann WR; Heck AJR
    J Biol Chem; 2009 Jun; 284(24):16354-16368. PubMed ID: 19369251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle.
    Hayden MA; Nakayama DK
    J Surg Res; 1999 Apr; 82(2):222-7. PubMed ID: 10090833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
    Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
    Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase G activity prevents pathological-level nitric oxide-induced apoptosis and promotes DNA synthesis/cell proliferation in vascular smooth muscle cells.
    Wong JC; Fiscus RR
    Cardiovasc Pathol; 2010; 19(6):e221-31. PubMed ID: 20060325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart.
    Krieg T; Philipp S; Cui L; Dostmann WR; Downey JM; Cohen MV
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1976-81. PubMed ID: 15591097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis.
    Koika V; Zhou Z; Vasileiadis I; Roussos C; Finetti F; Monti M; Morbidelli L; Papapetropoulos A
    Vascul Pharmacol; 2010; 53(5-6):215-22. PubMed ID: 20813203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP-dependent protein kinase activity in rat pulmonary microvascular endothelial cells.
    Diwan AH; Thompson WJ; Lee AK; Strada SJ
    Biochem Biophys Res Commun; 1994 Jul; 202(2):728-35. PubMed ID: 8048944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
    Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.
    Moon TM; Tykocki NR; Sheehe JL; Osborne BW; Tegge W; Brayden JE; Dostmann WR
    Chem Biol; 2015 Dec; 22(12):1653-61. PubMed ID: 26687482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of voltage-dependent Ba2+ currents in the guinea-pig gastric antrum by cyclic nucleotide-dependent pathways.
    Zhu HL; Hirst GD; Ito Y; Teramoto N
    Br J Pharmacol; 2005 Sep; 146(1):129-38. PubMed ID: 15965497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
    Zhuplatov SB; Masaki T; Blumenthal DK; Cheung AK
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):431-9. PubMed ID: 17169124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.